The compound pharmaceutical formulation, a process for inhibiting 5alfa - reductase, processes for treating benign hyperplasia of the nut, and androgenica seborrhea alopecia

摘要

The invention relates to 1,2,3,4,5,6-hexahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds, and their use as steroid 5 alpha -reductase inhibitors.